Literature DB >> 21992985

Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya.

Nelly Mugo1, Sufia S Dadabhai, Rebecca Bunnell, John Williamson, Eddas Bennett, Isaack Baya, Nelly Akinyi, Ibrahim Mohamed, Reinhard Kaiser.   

Abstract

BACKGROUND: Herpes simplex virus type 2 (HSV-2) is a known biologic cofactor for human immunodeficiency virus (HIV) transmission and acquisition. The Kenya AIDS Indicator Survey 2007 provided Kenya's first nationally representative estimate of HSV-2 prevalence and risk factors.
METHODS: KAIS was a household serosurvey among women and men aged 15 to 64 years. The survey included a behavioral interview and serum testing for HSV-2, HIV, and syphilis infections. Results were weighted for sampling design and nonresponse.
RESULTS: Of 19,840 eligible individuals, 90% completed an interview and 80% consented to testing. In all, 35% were infected with HSV-2, of which 42% were women and 26% were men. Between 15 and 24 years of age, HSV-2 prevalence increased from 7% to 34% in women and 3% to 14% in men. Among couples, 30% were HSV-2 concordant-positive, 21% were discordant, and 49% were concordant-negative. In all, 81% of HIV-infected persons were coinfected with HSV-2. HIV prevalence was 16% among those with HSV-2 and 2% among those without HSV-2. Women with circumcised partners had an HSV-2 prevalence of 39% compared to 77% of women with uncircumcised partners.
CONCLUSIONS: One-third of Kenyans were HSV-2 infected. HIV-1 infection, age, female sex, and lack of male circumcision were population-level predictors for HSV-2 infection. Targeted prevention interventions are needed, including an effective vaccine.

Entities:  

Mesh:

Year:  2011        PMID: 21992985     DOI: 10.1097/OLQ.0b013e31822e60b6

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  29 in total

1.  Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease.

Authors:  Briana Nixon; Esra Fakioglu; Martha Stefanidou; Yanhua Wang; Monica Dutta; Harris Goldstein; Betsy C Herold
Journal:  J Infect Dis       Date:  2013-08-29       Impact factor: 5.226

Review 2.  Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions.

Authors:  Ruanne V Barnabas; Connie Celum
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

3.  Changes in the soluble mucosal immune environment during genital herpes outbreaks.

Authors:  Marla J Keller; Rebecca P Madan; Gail Shust; Colleen A Carpenter; N Merna Torres; Sylvia Cho; Hnin Khine; Meei-Li Huang; Lawrence Corey; Mimi Kim; Betsy C Herold
Journal:  J Acquir Immune Defic Syndr       Date:  2012-10-01       Impact factor: 3.731

4.  Disclosure of HSV-2 serological test results in the context of an adolescent HIV prevention trial in Kenya.

Authors:  Denise Dion Hallfors; Hyunsan Cho; Isabella I Mbai; Benson W Millimo; Carolyne Atieno; David Okumu; Winnie K Luseno; Shane Hartman; Carolyn T Halpern; Marcia M Hobbs
Journal:  Sex Transm Infect       Date:  2015-07-02       Impact factor: 3.519

5.  Impacts of multisectoral cash plus programs after four years in an urban informal settlement: Adolescent Girls Initiative-Kenya (AGI-K) randomized trial.

Authors:  Beth Kangwana; Karen Austrian; Erica Soler-Hampejsek; Nicole Maddox; Rachel J Sapire; Yohannes Dibaba Wado; Benta Abuya; Eva Muluve; Faith Mbushi; Joy Koech; John A Maluccio
Journal:  PLoS One       Date:  2022-02-07       Impact factor: 3.240

6.  [Male circumcision from an infectiological point of view].

Authors:  H Schöfer
Journal:  Hautarzt       Date:  2015-01       Impact factor: 0.751

7.  Sexually transmitted infections and male circumcision: a systematic review and meta-analysis.

Authors:  Robert S Van Howe
Journal:  ISRN Urol       Date:  2013-04-16

8.  Herpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections.

Authors:  Brent Stanfield; Konstantin Gus Kousoulas
Journal:  Curr Clin Microbiol Rep       Date:  2015-07-01

9.  Incident HSV-2 infections are common among HIV-1-discordant couples.

Authors:  Anthony N Muiru; Brandon L Guthrie; Rose Bosire; Michele Merkel; Amy Y Liu; Robert Y Choi; Barbara Lohman-Payne; Ann Gatuguta; Romel D Mackelprang; James N Kiarie; Carey Farquhar
Journal:  J Infect Dis       Date:  2013-07-09       Impact factor: 5.226

10.  Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda.

Authors:  Anne F Rositch; Patti E Gravitt; Aaron A R Tobian; Kevin Newell; Thomas C Quinn; David Serwadda; Paschal Ssebbowa; Valerian Kiggundu; Ronald H Gray; Steven J Reynolds
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.